New Delhi, April 30, 2024: The Uttarakhand State Licensing Authority under Rule 159(1) of The Drugs and Cosmetics Rules, has moved to suspend the manufacturing licenses for 14 products of Patanjali, effective immediately.
In addition, the Uttarakhand licensing body has issued a formal apology before the Supreme Court regarding its previous handling of the matter.
In response to a plea filed by the Indian Medical Association, the Supreme Court had earlier criticized the Uttarakhand government and the licensing body for perceived negligence in reigning in Patanjali’s advertising practices.
The affidavit submitted by the Uttarakhand body emphasized its commitment to taking decisive action against Patanjali Ayurved Limited to uphold regulatory standards.
The Supreme Court had previously warned of imposing hefty fines for false claims made in Patanjali’s advertisements and had directed the company to cease such practices.
Despite initial dissatisfaction with the apology affidavits filed by Patanjali Ayurved and its founders, Baba Ramdev and Acharya Balkrishna, subsequent efforts were made to rectify the situation, including the publication of apologies in newspapers.
The matter is scheduled for further deliberation by a Bench of Justices Hima Kohli and Ahsanuddin Amanullah today, on April 30.
|